F&FFinancial Insights

Financial Metrics

EHC Encompass Health Corp
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 26 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2017-06-30 966400000.0 USD 10-Q 2018-08-02
Quarterly 2017-09-30 981600000.0 +1.6% USD 10-Q 2018-10-31
Quarterly 2018-03-31 1046000000.0 +6.6% USD 10-Q 2019-05-01
Quarterly 2018-06-30 1067700000.0 +2.1% USD 10-Q 2019-07-31
Quarterly 2018-09-30 1067600000.0 -0.0% USD 10-Q 2019-10-31
Quarterly 2019-03-31 1124000000.0 +5.3% USD 10-Q 2020-05-11
Quarterly 2019-06-30 1135000000.0 +1.0% USD 10-Q 2020-07-31
Quarterly 2019-09-30 1161600000.0 +2.3% USD 10-Q 2020-11-02
Quarterly 2020-03-31 1182000000.0 +1.8% USD 10-Q 2021-05-04
Quarterly 2020-06-30 1074100000.0 -9.1% USD 10-Q 2021-08-03
Quarterly 2020-09-30 1173900000.0 +9.3% USD 10-Q 2021-11-02
Quarterly 2021-03-31 1230400000.0 +4.8% USD 10-Q 2022-05-03
Quarterly 2021-06-30 1287700000.0 +4.7% USD 10-Q 2022-08-04
Quarterly 2021-09-30 1010800000.0 -21.5% USD 10-Q 2022-11-02
Quarterly 2022-03-31 1059300000.0 +4.8% USD 10-Q 2023-05-03
Quarterly 2022-06-30 1062500000.0 +0.3% USD 10-Q 2023-08-04
Quarterly 2022-09-30 1089500000.0 +2.5% USD 10-Q 2023-11-01
Quarterly 2023-03-31 1160400000.0 +6.5% USD 10-Q 2024-05-02
Quarterly 2023-06-30 1187100000.0 +2.3% USD 10-Q 2024-08-06
Quarterly 2023-09-30 1206900000.0 +1.7% USD 10-Q 2024-11-01
Quarterly 2024-03-31 1316000000.0 +9.0% USD 10-Q 2025-05-01
Quarterly 2024-06-30 1301200000.0 -1.1% USD 10-Q 2025-08-06
Quarterly 2024-09-30 1351000000.0 +3.8% USD 10-Q 2025-10-31
Quarterly 2025-03-31 1455400000.0 +7.7% USD 10-Q 2025-05-01
Quarterly 2025-06-30 1457700000.0 +0.2% USD 10-Q 2025-08-06
Quarterly 2025-09-30 1477500000.0 +1.4% USD 10-Q 2025-10-31
Annual 2016-12-31 3642600000.0 USD 10-K 2019-02-27
Annual 2017-12-31 3913900000.0 +7.4% USD 10-K 2020-02-27
Annual 2018-12-31 4277300000.0 +9.3% USD 10-K 2021-02-26
Annual 2019-12-31 4605000000.0 +7.7% USD 10-K 2022-02-25
Annual 2020-12-31 3566300000.0 -22.6% USD 10-K 2023-02-27
Annual 2021-12-31 4014900000.0 +12.6% USD 10-K 2024-02-28
Annual 2022-12-31 4348600000.0 +8.3% USD 10-K 2025-02-28
Annual 2023-12-31 4801200000.0 +10.4% USD 10-K 2026-02-26
Annual 2024-12-31 5373200000.0 +11.9% USD 10-K 2026-02-26
Annual 2025-12-31 5935200000.0 +10.5% USD 10-K 2026-02-26

Gross Profit

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Operating Income

Q: 0 | A: 7

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2016-12-31 145500000.0 USD 10-K 2018-02-28
Annual 2017-12-31 144700000.0 -0.5% USD 10-K 2019-02-27
Annual 2018-12-31 93400000.0 -35.5% USD 10-K 2020-02-27
Annual 2019-12-31 141200000.0 +51.2% USD 10-K 2021-02-26
Annual 2020-12-31 168300000.0 +19.2% USD 10-K 2021-02-26
Annual 2021-12-31 128400000.0 -23.7% USD 10-K 2023-02-27
Annual 2022-12-31 151900000.0 +18.3% USD 10-K 2023-02-27

Net Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 76700000.0 USD 10-Q 2017-04-28
Quarterly 2016-06-30 81200000.0 +5.9% USD 10-Q 2017-08-02
Quarterly 2016-09-30 78100000.0 -3.8% USD 10-Q 2017-10-31
Quarterly 2017-03-31 84400000.0 +8.1% USD 10-Q 2018-05-02
Quarterly 2017-06-30 79400000.0 -5.9% USD 10-Q 2018-08-02
Quarterly 2017-09-30 85100000.0 +7.2% USD 10-Q 2018-10-31
Quarterly 2018-03-31 105200000.0 +23.6% USD 10-Q 2019-05-01
Quarterly 2018-06-30 113200000.0 +7.6% USD 10-Q 2019-07-31
Quarterly 2018-09-30 109300000.0 -3.4% USD 10-Q 2019-10-31
Quarterly 2019-03-31 125200000.0 +14.5% USD 10-Q 2020-05-11
Quarterly 2019-06-30 110900000.0 -11.4% USD 10-Q 2020-07-31
Quarterly 2019-09-30 119500000.0 +7.8% USD 10-Q 2020-11-02
Quarterly 2020-03-31 108700000.0 -9.0% USD 10-Q 2021-05-04
Quarterly 2020-06-30 48300000.0 -55.6% USD 10-Q 2021-08-03
Quarterly 2020-09-30 100100000.0 +107.2% USD 10-Q 2021-11-02
Quarterly 2021-03-31 132800000.0 +32.7% USD 10-Q 2022-05-03
Quarterly 2021-06-30 142000000.0 +6.9% USD 10-Q 2022-08-04
Quarterly 2021-09-30 126700000.0 -10.8% USD 10-Q 2022-11-02
Quarterly 2022-03-31 110100000.0 -13.1% USD 10-Q 2023-05-03
Quarterly 2022-06-30 71300000.0 -35.2% USD 10-Q 2023-08-04
Quarterly 2022-09-30 67000000.0 -6.0% USD 10-Q 2023-11-01
Quarterly 2023-03-31 113300000.0 +69.1% USD 10-Q 2024-05-02
Quarterly 2023-06-30 117200000.0 +3.4% USD 10-Q 2024-08-06
Quarterly 2023-09-30 113400000.0 -3.2% USD 10-Q 2024-11-01
Quarterly 2024-03-31 138800000.0 +22.4% USD 10-Q 2025-05-01
Quarterly 2024-06-30 146500000.0 +5.5% USD 10-Q 2025-08-06
Quarterly 2024-09-30 147100000.0 +0.4% USD 10-Q 2025-10-31
Quarterly 2025-03-31 196500000.0 +33.6% USD 10-Q 2025-05-01
Quarterly 2025-06-30 184900000.0 -5.9% USD 10-Q 2025-08-06
Quarterly 2025-09-30 174600000.0 -5.6% USD 10-Q 2025-10-31
Annual 2016-12-31 318100000.0 USD 10-K 2019-02-27
Annual 2017-12-31 350200000.0 +10.1% USD 10-K 2020-02-27
Annual 2018-12-31 375400000.0 +7.2% USD 10-K 2021-02-26
Annual 2019-12-31 445800000.0 +18.8% USD 10-K 2022-02-25
Annual 2020-12-31 368800000.0 -17.3% USD 10-K 2023-02-27
Annual 2021-12-31 517200000.0 +40.2% USD 10-K 2024-02-28
Annual 2022-12-31 365900000.0 -29.3% USD 10-K 2025-02-28
Annual 2023-12-31 463000000.0 +26.5% USD 10-K 2026-02-26
Annual 2024-12-31 596600000.0 +28.9% USD 10-K 2026-02-26
Annual 2025-12-31 759100000.0 +27.2% USD 10-K 2026-02-26

EPS Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 0.65 USD/shares 10-Q 2017-04-28
Quarterly 2016-06-30 0.7 +7.7% USD/shares 10-Q 2017-08-02
Quarterly 2016-09-30 0.69 -1.4% USD/shares 10-Q 2017-10-31
Quarterly 2017-03-31 0.75 +8.7% USD/shares 10-Q 2018-05-02
Quarterly 2017-06-30 0.7 -6.7% USD/shares 10-Q 2018-08-02
Quarterly 2017-09-30 0.67 -4.3% USD/shares 10-Q 2018-10-31
Quarterly 2018-03-31 0.85 +26.9% USD/shares 10-Q 2019-05-01
Quarterly 2018-06-30 0.93 +9.4% USD/shares 10-Q 2019-07-31
Quarterly 2018-09-30 0.9 -3.2% USD/shares 10-Q 2019-10-31
Quarterly 2019-03-31 1.04 +15.6% USD/shares 10-Q 2020-05-11
Quarterly 2019-06-30 0.93 -10.6% USD/shares 10-Q 2020-07-31
Quarterly 2019-09-30 0.99 +6.5% USD/shares 10-Q 2020-11-02
Quarterly 2020-03-31 0.88 -11.1% USD/shares 10-Q 2021-05-04
Quarterly 2020-06-30 0.34 -61.4% USD/shares 10-Q 2021-08-03
Quarterly 2020-09-30 0.78 +129.4% USD/shares 10-Q 2021-11-02
Quarterly 2021-03-31 1.08 +38.5% USD/shares 10-Q 2022-05-03
Quarterly 2021-06-30 1.14 +5.6% USD/shares 10-Q 2022-08-04
Quarterly 2021-09-30 1.0 -12.3% USD/shares 10-Q 2022-11-02
Quarterly 2022-03-31 0.88 -12.0% USD/shares 10-Q 2023-05-03
Quarterly 2022-06-30 0.49 -44.3% USD/shares 10-Q 2023-08-04
Quarterly 2022-09-30 0.45 -8.2% USD/shares 10-Q 2023-11-01
Quarterly 2023-03-31 0.88 +95.6% USD/shares 10-Q 2024-05-02
Quarterly 2023-06-30 0.91 +3.4% USD/shares 10-Q 2024-08-06
Quarterly 2023-09-30 0.85 -6.6% USD/shares 10-Q 2024-11-01
Quarterly 2024-03-31 1.12 +31.8% USD/shares 10-Q 2025-05-01
Quarterly 2024-06-30 1.13 +0.9% USD/shares 10-Q 2025-08-06
Quarterly 2024-09-30 1.08 -4.4% USD/shares 10-Q 2025-10-31
Quarterly 2025-03-31 1.5 +38.9% USD/shares 10-Q 2025-05-01
Quarterly 2025-06-30 1.41 -6.0% USD/shares 10-Q 2025-08-06
Quarterly 2025-09-30 1.26 -10.6% USD/shares 10-Q 2025-10-31
Annual 2016-12-31 2.77 USD/shares 10-K 2019-02-27
Annual 2017-12-31 2.88 +4.0% USD/shares 10-K 2020-02-27
Annual 2018-12-31 2.98 +3.5% USD/shares 10-K 2021-02-26
Annual 2019-12-31 3.65 +22.5% USD/shares 10-K 2022-02-25
Annual 2020-12-31 2.87 -21.4% USD/shares 10-K 2023-02-27
Annual 2021-12-31 4.15 +44.6% USD/shares 10-K 2024-02-28
Annual 2022-12-31 2.72 -34.5% USD/shares 10-K 2025-02-28
Annual 2023-12-31 3.51 +29.0% USD/shares 10-K 2026-02-26
Annual 2024-12-31 4.53 +29.1% USD/shares 10-K 2026-02-26
Annual 2025-12-31 5.62 +24.1% USD/shares 10-K 2026-02-26

EPS Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 0.61 USD/shares 10-Q 2017-04-28
Quarterly 2016-06-30 0.65 +6.6% USD/shares 10-Q 2017-08-02
Quarterly 2016-09-30 0.64 -1.5% USD/shares 10-Q 2017-10-31
Quarterly 2017-03-31 0.7 +9.4% USD/shares 10-Q 2018-05-02
Quarterly 2017-06-30 0.7 +0.0% USD/shares 10-Q 2018-08-02
Quarterly 2017-09-30 0.67 -4.3% USD/shares 10-Q 2018-10-31
Quarterly 2018-03-31 0.84 +25.4% USD/shares 10-Q 2019-05-01
Quarterly 2018-06-30 0.92 +9.5% USD/shares 10-Q 2019-07-31
Quarterly 2018-09-30 0.89 -3.3% USD/shares 10-Q 2019-10-31
Quarterly 2019-03-31 1.03 +15.7% USD/shares 10-Q 2020-05-11
Quarterly 2019-06-30 0.92 -10.7% USD/shares 10-Q 2020-07-31
Quarterly 2019-09-30 0.98 +6.5% USD/shares 10-Q 2020-11-02
Quarterly 2020-03-31 0.87 -11.2% USD/shares 10-Q 2021-05-04
Quarterly 2020-06-30 0.34 -60.9% USD/shares 10-Q 2021-08-03
Quarterly 2020-09-30 0.78 +129.4% USD/shares 10-Q 2021-11-02
Quarterly 2021-03-31 1.07 +37.2% USD/shares 10-Q 2022-05-03
Quarterly 2021-06-30 1.13 +5.6% USD/shares 10-Q 2022-08-04
Quarterly 2021-09-30 1.0 -11.5% USD/shares 10-Q 2022-11-02
Quarterly 2022-03-31 0.87 -13.0% USD/shares 10-Q 2023-05-03
Quarterly 2022-06-30 0.49 -43.7% USD/shares 10-Q 2023-08-04
Quarterly 2022-09-30 0.45 -8.2% USD/shares 10-Q 2023-11-01
Quarterly 2023-03-31 0.87 +93.3% USD/shares 10-Q 2024-05-02
Quarterly 2023-06-30 0.9 +3.4% USD/shares 10-Q 2024-08-06
Quarterly 2023-09-30 0.84 -6.7% USD/shares 10-Q 2024-11-01
Quarterly 2024-03-31 1.1 +31.0% USD/shares 10-Q 2025-05-01
Quarterly 2024-06-30 1.12 +1.8% USD/shares 10-Q 2025-08-06
Quarterly 2024-09-30 1.06 -5.4% USD/shares 10-Q 2025-10-31
Quarterly 2025-03-31 1.48 +39.6% USD/shares 10-Q 2025-05-01
Quarterly 2025-06-30 1.39 -6.1% USD/shares 10-Q 2025-08-06
Quarterly 2025-09-30 1.24 -10.8% USD/shares 10-Q 2025-10-31
Annual 2016-12-31 2.59 USD/shares 10-K 2019-02-27
Annual 2017-12-31 2.84 +9.7% USD/shares 10-K 2020-02-27
Annual 2018-12-31 2.93 +3.2% USD/shares 10-K 2021-02-26
Annual 2019-12-31 3.61 +23.2% USD/shares 10-K 2022-02-25
Annual 2020-12-31 2.85 -21.1% USD/shares 10-K 2023-02-27
Annual 2021-12-31 4.11 +44.2% USD/shares 10-K 2024-02-28
Annual 2022-12-31 2.7 -34.3% USD/shares 10-K 2025-02-28
Annual 2023-12-31 3.47 +28.5% USD/shares 10-K 2026-02-26
Annual 2024-12-31 4.46 +28.5% USD/shares 10-K 2026-02-26
Annual 2025-12-31 5.54 +24.2% USD/shares 10-K 2026-02-26

8-K Material Event Details

66 filings · 147 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

229 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-03-09 Fay Edmund Sr. Vice Pres. and Treasurer Equity grant / award
G
Encompass Health Common Stock 3,000 $0.00 $0 86,325
2026-03-09 Fay Edmund Sr. Vice Pres. and Treasurer Open-market sell
S
Encompass Health Common Stock 11,937 $107.00 $1,277,259 89,325
2026-02-28 Price Andrew L Chief Accounting Officer Other disposed transaction
F
Encompass Health Common Stock 307 $107.88 $33,119 74,694
2026-02-23 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 2,488 $106.15 $264,101 443,149
2026-02-20 Charbonneau Elissa Joy Chief Medical Officer Other disposed transaction
F
Encompass Health Common Stock 287 $106.55 $30,580 18,453
2026-02-19 Charbonneau Elissa Joy Chief Medical Officer Equity grant / award
A
Encompass Health Common Stock 1,884 $0.00 $0 22,756
2026-02-19 Charbonneau Elissa Joy Chief Medical Officer Other disposed transaction
F
Encompass Health Common Stock 4,016 $107.15 $430,314 18,740
2026-02-18 Charbonneau Elissa Joy Chief Medical Officer Equity grant / award
A
Encompass Health Common Stock 8,914 $0.00 $0 20,872
2026-02-11 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 213 $113.58 $24,193 377,070
2026-02-11 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 87,745 $113.09 $9,923,082 377,283
2026-02-11 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 6,057 $111.89 $677,718 465,028
2026-02-11 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 10,954 $110.92 $1,215,018 471,085
2026-02-11 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 15,584 $110.07 $1,715,331 482,039
2026-02-11 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 13,231 $108.80 $1,439,533 497,623
2026-02-11 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 16,216 $108.03 $1,751,814 510,854
2026-02-10 Tuer Patrick William EVP, Chief Operating Officer Open-market sell
S
Encompass Health Common Stock 2,804 $107.62 $301,766 16,042
2026-01-30 Hayes Cain A Dir Equity grant / award
A
Encompass Health Common Stock 457 $0.00 $0 457
2026-01-15 CARMICHAEL GREG D Dir Equity grant / award
A
Encompass Health Common Stock 28 $0.00 $0 18,659
2025-10-15 CARMICHAEL GREG D Dir Equity grant / award
A
Encompass Health Common Stock 23 $0.00 $0 18,631
2025-08-27 Tuer Patrick William EVP, Chief Operating Officer Open-market sell
S
Encompass Health Common Stock 1,020 $123.59 $126,062 18,846
2025-08-21 COLTHARP DOUGLAS E EVP & Chief Financial Officer Equity grant / award
G
Encompass Health Common Stock 27,480 $0.00 $0 27,480
2025-07-16 Reidy Christopher R Dir Equity grant / award
A
Encompass Health Common Stock 333 $106.89 $35,594 14,781
2025-07-15 Reidy Christopher R Dir Equity grant / award
A
Encompass Health Common Stock 17 $0.00 $0 14,448
2025-05-20 Tarr Mark J President & CEO Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 62,078 $0.00 $0 0
2025-05-20 Tarr Mark J President & CEO Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 56,306 $0.00 $0 0
2025-05-20 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 118,290 $121.53 $14,375,784 527,070
2025-05-20 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 94 $120.94 $11,368 645,360
2025-05-20 Tarr Mark J President & CEO Exercise / conversion
M
Encompass Health Common Stock 62,078 $44.67 $2,773,024 645,454
2025-05-20 Tarr Mark J President & CEO Exercise / conversion
M
Encompass Health Common Stock 56,306 $35.06 $1,974,088 583,376
2025-05-14 Fay Edmund Sr. Vice Pres. and Treasurer Equity grant / award
G
Encompass Health Common Stock 3,667 $0.00 $0 96,489
2025-05-06 Charbonneau Elissa Joy Chief Medical Officer Open-market sell
S
Encompass Health Common Stock 4,279 $116.61 $498,974 11,958
2025-05-01 CARMICHAEL GREG D Dir Equity grant / award
A
Encompass Health Common Stock 1,424 $0.00 $0 18,584
2025-04-30 Tuer Patrick William EVP, Chief Operating Officer Equity grant / award
A
Encompass Health Common Stock 5,984 $0.00 $0 19,866
2025-04-29 Darby John Patrick EVP, Gen Counsel & Secretary Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 10,000 $0.00 $0 4,858
2025-04-29 Darby John Patrick EVP, Gen Counsel & Secretary Open-market sell
S
Encompass Health Common Stock 10,000 $114.79 $1,147,900 79,710
2025-04-29 Darby John Patrick EVP, Gen Counsel & Secretary Exercise / conversion
M
Encompass Health Common Stock 10,000 $35.06 $350,600 89,710
2025-04-24 Christie Edward M III Dir Equity grant / award
A
Encompass Health Common Stock 268 $102.56 $27,486 4,982
2025-04-22 Reidy Christopher R Dir Equity grant / award
A
Encompass Health Common Stock 360 $98.23 $35,363 13,007
2025-04-15 Maryland Patricia Anne Dir Equity grant / award
A
Encompass Health Common Stock 23 $0.00 $0 13,316
2025-03-04 COLTHARP DOUGLAS E EVP & Chief Financial Officer Equity grant / award
A · derivative
Non-qualified Stock Option (Right to Buy) 12,407 $98.45 $1,221,469 12,407
2025-02-28 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 2,187 $100.14 $219,006 527,070
2025-02-25 Charbonneau Elissa Joy Chief Medical Officer Other disposed transaction
F
Encompass Health Common Stock 506 $100.63 $50,919 16,601
2025-02-24 Charbonneau Elissa Joy Chief Medical Officer Other disposed transaction
F
Encompass Health Common Stock 435 $97.53 $42,426 17,107
2025-02-20 COLTHARP DOUGLAS E EVP & Chief Financial Officer Equity grant / award
A
Encompass Health Common Stock 4,557 $0.00 $0 63,117
2025-02-13 Price Andrew L Chief Accounting Officer Open-market sell
S
Encompass Health Common Stock 5,042 $98.29 $495,578 69,164
2025-01-15 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 25 $0.00 $0 13,647
2025-01-01 Charbonneau Elissa Joy Chief Medical Officer Other disposed transaction
F
Encompass Health Common Stock 2,991 $92.35 $276,219 15,603
2024-11-13 COLTHARP DOUGLAS E EVP & Chief Financial Officer Equity grant / award
G
Encompass Health Common Stock 65,229 $0.00 $0 65,229
2024-10-15 CARMICHAEL GREG D Dir Equity grant / award
A
Encompass Health Common Stock 24 $0.00 $0 17,112
2024-10-15 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 24 $0.00 $0 13,622
2024-08-13 COLTHARP DOUGLAS E EVP & Chief Financial Officer Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 12,260 $0.00 $0 0
2024-08-13 COLTHARP DOUGLAS E EVP & Chief Financial Officer Open-market sell
S
Encompass Health Common Stock 98 $87.03 $8,529 136,227
2024-08-13 COLTHARP DOUGLAS E EVP & Chief Financial Officer Open-market sell
S
Encompass Health Common Stock 12,162 $86.33 $1,049,945 136,325
2024-08-13 COLTHARP DOUGLAS E EVP & Chief Financial Officer Exercise / conversion
M
Encompass Health Common Stock 12,260 $35.83 $439,276 148,487
2024-07-15 CARMICHAEL GREG D Dir Equity grant / award
L
Encompass Health Common Stock 7 $86.89 $608 17,088
2024-07-15 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 24 $0.00 $0 13,598
2024-05-24 Charbonneau Elissa Joy Chief Medical Officer Open-market sell
S
Encompass Health Common Stock 10,000 $85.02 $850,200 18,594
2024-05-06 Darby John Patrick EVP, Gen Counsel & Secretary Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 14,543 $0.00 $0 0
2024-05-06 Darby John Patrick EVP, Gen Counsel & Secretary Open-market sell
S
Encompass Health Common Stock 14,543 $83.94 $1,220,739 84,773
2024-05-06 Darby John Patrick EVP, Gen Counsel & Secretary Exercise / conversion
M
Encompass Health Common Stock 14,543 $29.06 $422,620 99,316
2024-05-03 CARMICHAEL GREG D Dir Open-market buy
P
Encompass Health Common Stock 2,000 $83.73 $167,460 17,050
2024-05-02 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 1,978 $0.00 $0 13,574
2024-04-30 Tarr Mark J President & CEO Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 25,516 $0.00 $0 0
2024-04-30 Tarr Mark J President & CEO Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 19,460 $0.00 $0 0
2024-04-30 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 44,976 $83.27 $3,745,152 554,098
2024-04-30 Tarr Mark J President & CEO Exercise / conversion
M
Encompass Health Common Stock 25,516 $29.06 $741,495 599,074
2024-04-30 Tarr Mark J President & CEO Exercise / conversion
M
Encompass Health Common Stock 19,460 $35.83 $697,252 573,558
2024-04-16 Christie Edward M III Dir Equity grant / award
A
Encompass Health Common Stock 314 $79.65 $25,010 1,804
2024-04-15 CARMICHAEL GREG D Dir Equity grant / award
L
Encompass Health Common Stock 3 $81.47 $244 13,079
2024-04-15 Christie Edward M III Dir Equity grant / award
A
Encompass Health Common Stock 2 $0.00 $0 1,490
2024-02-28 Price Andrew L Chief Accounting Officer Equity grant / award
A
Encompass Health Common Stock 2,069 $0.00 $0 76,652
2024-02-28 Price Andrew L Chief Accounting Officer Equity grant / award
A
Encompass Health Common Stock 5,329 $0.00 $0 74,583
2024-02-25 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 2,895 $75.25 $217,849 464,598
2024-02-24 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 2,256 $75.25 $169,764 467,493
2024-02-23 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 2,487 $75.25 $187,147 469,749
2024-01-16 CARMICHAEL GREG D Dir Equity grant / award
L
Encompass Health Common Stock 4 $68.64 $275 13,055
2024-01-02 Charbonneau Elissa Joy Chief Medical Officer Other disposed transaction
F
Encompass Health Common Stock 2,281 $66.72 $152,188 20,800
2023-11-27 Christie Edward M III Dir Equity grant / award
A
Encompass Health Common Stock 997 $0.00 $0 997
2023-11-13 COLTHARP DOUGLAS E EVP & Chief Financial Officer Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 16,623 $0.00 $0 0
2023-11-13 COLTHARP DOUGLAS E EVP & Chief Financial Officer Open-market sell
S
Encompass Health Common Stock 11,215 $63.39 $710,919 116,293
2023-11-13 COLTHARP DOUGLAS E EVP & Chief Financial Officer Exercise / conversion
M
Encompass Health Common Stock 16,623 $26.55 $441,341 127,508
2023-10-16 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 27 $0.00 $0 11,551
2023-08-17 Charbonneau Elissa Joy Chief Medical Officer Open-market sell
S
Encompass Health Common Stock 8,294 $69.58 $577,097 23,081
2023-08-16 Tarr Mark J President & CEO Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 25,330 $0.00 $0 0
2023-08-16 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 25,330 $71.06 $1,799,950 497,405
2023-08-16 Tarr Mark J President & CEO Exercise / conversion
M
Encompass Health Common Stock 25,330 $26.55 $672,512 522,735
2023-07-17 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 25 $0.00 $0 11,524
2023-05-04 CHIDSEY JOHN Dir Equity grant / award
A
Encompass Health Common Stock 2,385 $0.00 $0 160,302
2023-04-18 CHIDSEY JOHN Dir Equity grant / award
A
Encompass Health Common Stock 687 $61.51 $42,257 157,917
2023-04-17 CHIDSEY JOHN Dir Equity grant / award
A
Encompass Health Common Stock 223 $0.00 $0 157,230
2023-03-01 Tarr Mark J President & CEO Equity grant / award
A · derivative
Non-qualified Stock Option (Right to Buy) 49,498 $0.00 $0 49,498
2023-02-27 Darby John Patrick EVP, Gen Counsel & Secretary Other disposed transaction
F
Encompass Health Common Stock 509 $60.22 $30,652 75,108
2023-02-24 Darby John Patrick EVP, Gen Counsel & Secretary Other disposed transaction
F
Encompass Health Common Stock 397 $60.22 $23,907 75,617
2023-02-23 Tarr Mark J President & CEO Equity grant / award
A
Encompass Health Common Stock 16,824 $0.00 $0 502,546
2023-02-23 Tarr Mark J President & CEO Equity grant / award
A
Encompass Health Common Stock 61,503 $0.00 $0 485,722
2023-02-21 Charbonneau Elissa Joy Chief Medical Officer Other disposed transaction
F
Encompass Health Common Stock 332 $62.86 $20,870 24,356
2023-02-10 COLTHARP DOUGLAS E EVP & Chief Financial Officer Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 17,895 $0.00 $0 0
2023-02-10 COLTHARP DOUGLAS E EVP & Chief Financial Officer Open-market sell
S
Encompass Health Common Stock 17,895 $60.78 $1,087,658 53,097
2023-02-10 COLTHARP DOUGLAS E EVP & Chief Financial Officer Exercise / conversion
M
Encompass Health Common Stock 17,895 $20.07 $359,153 70,992
2023-01-17 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 22 $0.00 $0 9,092
2023-01-03 COLTHARP DOUGLAS E EVP & Chief Financial Officer Other disposed transaction
F
Encompass Health Common Stock 6,449 $59.81 $385,715 53,097
2022-10-31 CARMICHAEL GREG D Dir Open-market buy
P
Encompass Health Common Stock 1,830 $54.67 $100,046 10,546
2022-10-18 Reidy Christopher R Dir Equity grant / award
A
Encompass Health Common Stock 507 $49.70 $25,198 6,085
2022-10-17 Reidy Christopher R Dir Equity grant / award
A
Encompass Health Common Stock 13 $0.00 $0 5,578
2022-08-17 Tarr Mark J President & CEO Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 20,449 $0.00 $0 0
2022-08-17 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 20,449 $53.25 $1,088,909 440,895
2022-08-17 Tarr Mark J President & CEO Exercise / conversion
M
Encompass Health Common Stock 20,449 $20.07 $410,411 461,344
2022-08-01 Reidy Christopher R Dir Equity grant / award
A
Encompass Health Common Stock 496 $50.78 $25,187 4,709
2022-07-20 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 50 $0.00 $0 7,577
2022-07-01 Encompass Health Corp 10% Other disposed transaction
J
Common Stock 3,853,248 $0.00 $0 0
2022-05-05 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 2,226 $0.00 $0 7,527
2022-04-18 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 20 $0.00 $0 5,301
2022-03-30 O'Connor Kevin J. Dir Equity grant / award
A
Encompass Health Common Stock 209 $0.00 $0 209
2022-03-01 Tarr Mark J President & CEO Equity grant / award
A · derivative
Non-qualified Stock Option (Right to Buy) 61,039 $0.00 $0 61,039
2022-02-25 Tarr Mark J President & CEO Equity grant / award
A
Encompass Health Common Stock 31,730 $0.00 $0 428,557
2022-02-25 Tarr Mark J President & CEO Equity grant / award
A
Encompass Health Common Stock 16,258 $0.00 $0 396,827
2022-02-24 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 1,873 $65.52 $122,719 380,569
2022-02-22 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 3,782 $65.91 $249,272 382,442
2022-02-08 COLTHARP DOUGLAS E EVP & Chief Financial Officer Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 26,132 $0.00 $0 0
2022-02-08 COLTHARP DOUGLAS E EVP & Chief Financial Officer Other disposed transaction
F
Encompass Health Common Stock 16,509 $62.15 $1,026,034 39,046
2022-02-08 COLTHARP DOUGLAS E EVP & Chief Financial Officer Exercise / conversion
M
Encompass Health Common Stock 26,132 $21.02 $549,295 55,555
2022-01-21 Reidy Christopher R Dir Equity grant / award
A
Encompass Health Common Stock 399 $62.51 $24,941 1,612
2022-01-20 CHIDSEY JOHN Dir Equity grant / award
A
Encompass Health Common Stock 498 $62.59 $31,170 124,276
2022-01-18 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 23 $0.00 $0 5,281
2022-01-03 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 11,327 $65.26 $739,200 386,224
2021-12-10 HIGDON LEO I JR Dir Equity grant / award
G
Encompass Health Common Stock 75,287 $0.00 $0 75,287
2021-12-02 Williams Terrance Dir Open-market buy
P
Encompass Health Common Stock 354 $56.61 $20,040 5,258
2021-11-09 COLTHARP DOUGLAS E EVP & Chief Financial Officer Equity grant / award
G
Encompass Health Common Stock 44,600 $0.00 $0 125,631
2021-10-15 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 21 $0.00 $0 4,904
2021-10-01 Reidy Christopher R Dir Equity grant / award
A
Encompass Health Common Stock 1,202 $0.00 $0 1,202
2021-07-15 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 18 $0.00 $0 4,883
2021-06-18 Anthony April Kaye Bullock CEO & President, Home Health Other disposed transaction
D
Encompass Health Common Stock 19,205 $0.00 $0 175,269
2021-05-06 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 1,757 $0.00 $0 4,865
2021-05-05 Anthony April Kaye Bullock CEO & President, Home Health Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 3,240 $0.00 $0 6,478
2021-05-05 Anthony April Kaye Bullock CEO & President, Home Health Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 4,343 $0.00 $0 2,172
2021-05-05 Anthony April Kaye Bullock CEO & President, Home Health Other disposed transaction
F
Encompass Health Common Stock 3,005 $84.68 $254,463 194,474
2021-05-05 Anthony April Kaye Bullock CEO & President, Home Health Exercise / conversion
M
Encompass Health Common Stock 3,240 $76.54 $247,990 197,479
2021-05-05 Anthony April Kaye Bullock CEO & President, Home Health Other disposed transaction
F
Encompass Health Common Stock 3,533 $84.68 $299,174 194,239
2021-05-05 Anthony April Kaye Bullock CEO & President, Home Health Exercise / conversion
M
Encompass Health Common Stock 4,343 $63.77 $276,953 197,772
2021-05-03 Anthony April Kaye Bullock CEO & President, Home Health Other disposed transaction
F
Encompass Health Common Stock 3,637 $84.44 $307,108 193,429
2021-04-15 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 11 $0.00 $0 3,108
2021-03-08 Price Andrew L Chief Accounting Officer Open-market sell
S
Encompass Health Common Stock 8,589 $81.40 $699,145 63,642
2021-03-02 Tarr Mark J President & CEO Equity grant / award
A · derivative
Non-qualified Stock Option (Right to Buy) 53,410 $0.00 $0 53,410
2021-02-24 Tarr Mark J President & CEO Equity grant / award
A
Encompass Health Common Stock 12,669 $0.00 $0 397,551
2021-02-24 Tarr Mark J President & CEO Equity grant / award
A
Encompass Health Common Stock 30,468 $0.00 $0 384,882
2021-02-24 Anthony April Kaye Bullock CEO & President, Home Health Equity grant / award
A
Encompass Health Common Stock 2,224 $0.00 $0 197,066
2021-02-24 Anthony April Kaye Bullock CEO & President, Home Health Equity grant / award
A
Encompass Health Common Stock 3,449 $0.00 $0 194,842
2021-02-23 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 1,975 $80.23 $158,454 354,414
2021-02-21 COLTHARP DOUGLAS E EVP & Chief Financial Officer Other disposed transaction
F
Encompass Health Common Stock 621 $80.51 $49,997 65,047
2021-02-20 COLTHARP DOUGLAS E EVP & Chief Financial Officer Other disposed transaction
F
Encompass Health Common Stock 650 $80.51 $52,332 65,668
2021-01-19 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 11 $0.00 $0 3,097
2021-01-04 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 22,894 $82.69 $1,893,105 360,171
2020-11-18 COLTHARP DOUGLAS E EVP & Chief Financial Officer Equity grant / award
G
Encompass Health Common Stock 81,031 $0.00 $0 81,031
2020-11-17 Charbonneau Elissa Joy Chief Medical Officer Open-market sell
S
Encompass Health Common Stock 6,650 $75.22 $500,213 20,111
2020-10-16 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 13 $0.00 $0 3,086
2020-07-16 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 14 $0.00 $0 3,073
2020-05-28 COLTHARP DOUGLAS E EVP & Chief Financial Officer Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 23,501 $0.00 $0 0
2020-05-28 COLTHARP DOUGLAS E EVP & Chief Financial Officer Open-market sell
S
Encompass Health Common Stock 490 $76.15 $37,314 157,268
2020-05-28 COLTHARP DOUGLAS E EVP & Chief Financial Officer Open-market sell
S
Encompass Health Common Stock 23,011 $75.73 $1,742,623 157,758
2020-05-28 COLTHARP DOUGLAS E EVP & Chief Financial Officer Exercise / conversion
M
Encompass Health Common Stock 23,501 $24.21 $568,959 180,769
2020-05-15 Jacobsmeyer Barbara Ann President, Inpatient Hospitals Open-market sell
S
Encompass Health Common Stock 2,500 $64.73 $161,825 44,761
2020-05-14 Tarr Mark J President & CEO Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 26,132 $0.00 $0 0
2020-05-14 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 26,132 $61.92 $1,618,093 383,065
2020-05-14 Tarr Mark J President & CEO Exercise / conversion
M
Encompass Health Common Stock 26,132 $21.02 $549,295 409,197
2020-05-06 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 2,304 $0.00 $0 3,059
2020-04-15 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 4 $0.00 $0 755
2020-03-12 CORRELL DONALD L Dir Open-market sell
S
Encompass Health Common Stock 2,000 $59.04 $118,080 70,568
2020-03-11 HIGDON LEO I JR Dir Open-market buy
P
Encompass Health Common Stock 1,000 $64.07 $64,070 73,738
2020-03-09 Jacobsmeyer Barbara Ann President, Inpatient Hospitals Equity grant / award
G
Encompass Health Common Stock 1,431 $0.00 $0 47,261
2020-03-06 Anthony April Kaye Bullock CEO & President, Home Health Equity grant / award
A
Encompass Health Common Stock 548,842 $82.56 $45,312,396 548,842
2020-03-02 Tarr Mark J President & CEO Equity grant / award
A · derivative
Non-qualified Stock Option (Right to Buy) 55,360 $0.00 $0 55,360
2020-02-24 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 1,975 $81.64 $161,239 383,065
2020-02-21 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 2,040 $81.64 $166,546 385,040
2020-02-20 Tarr Mark J President & CEO Equity grant / award
A
Encompass Health Common Stock 11,789 $0.00 $0 387,080
2020-02-20 Tarr Mark J President & CEO Equity grant / award
A
Encompass Health Common Stock 55,515 $0.00 $0 375,291
2020-02-20 Anthony April Kaye Bullock CEO & President, Home Health Equity grant / award
A
Encompass Health Common Stock 2,070 $0.00 $0 26,895
2020-02-18 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 2,005 $82.61 $165,633 319,776
2020-01-16 Williams Terrance Dir Equity grant / award
A
Encompass Health Common Stock 3 $0.00 $0 751
2020-01-02 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 20,596 $69.27 $1,426,685 321,781
2019-11-05 CURL YVONNE M Dir Open-market buy
P
Encompass Health Common Stock 500 $69.19 $34,595 71,555
2019-10-28 COLTHARP DOUGLAS E EVP & Chief Financial Officer Other disposed transaction
F
Encompass Health Common Stock 5,527 $67.49 $373,017 144,948
2019-10-16 HIGDON LEO I JR Dir Equity grant / award
A
Encompass Health Common Stock 298 $0.00 $0 72,488
2019-07-16 SHAW L EDWARD JR Dir Equity grant / award
A
Encompass Health Common Stock 61 $64.42 $3,930 91,536
2019-07-16 SHAW L EDWARD JR Dir Equity grant / award
A
Encompass Health Common Stock 288 $0.00 $0 91,475
2019-05-14 Jacobsmeyer Barbara Ann President, Inpatient Hospitals Equity grant / award
G
Encompass Health Common Stock 2,003 $0.00 $0 39,152
2019-05-03 SHAW L EDWARD JR Dir Equity grant / award
A
Encompass Health Common Stock 2,327 $0.00 $0 91,187
2019-05-01 Tarr Mark J President & CEO Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 23,501 $0.00 $0 0
2019-05-01 Tarr Mark J President & CEO Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 33,331 $0.00 $0 0
2019-05-01 Tarr Mark J President & CEO Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 10,550 $0.00 $0 0
2019-05-01 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 23,943 $63.23 $1,513,916 342,377
2019-05-01 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 43,439 $63.74 $2,768,802 366,320
2019-05-01 Tarr Mark J President & CEO Exercise / conversion
M
Encompass Health Common Stock 23,501 $24.21 $568,959 409,759
2019-05-01 Tarr Mark J President & CEO Exercise / conversion
M
Encompass Health Common Stock 33,331 $17.30 $576,626 386,258
2019-05-01 Tarr Mark J President & CEO Exercise / conversion
M
Encompass Health Common Stock 10,550 $14.95 $157,722 352,927
2019-04-23 SHAW L EDWARD JR Dir Equity grant / award
A
Encompass Health Common Stock 291 $0.00 $0 88,860
2019-04-23 SHAW L EDWARD JR Dir Equity grant / award
A
Encompass Health Common Stock 67 $61.34 $4,110 88,569
2019-03-07 HIGDON LEO I JR Dir Open-market buy
P
Encompass Health Common Stock 1,000 $58.84 $58,840 69,284
2019-03-01 Anthony April Kaye Bullock CEO & President, Home Health Equity grant / award
A · derivative
Non-qualified Stock Option (Right to Buy) 6,515 $0.00 $0 6,515
2019-02-25 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 1,975 $65.87 $130,093 342,377
2019-02-21 Fay Edmund Sr. Vice Pres. and Treasurer Equity grant / award
A
Encompass Health Common Stock 5,301 $0.00 $0 86,702
2019-02-21 Fay Edmund Sr. Vice Pres. and Treasurer Equity grant / award
A
Encompass Health Common Stock 1,889 $0.00 $0 81,401
2019-02-19 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 3,089 $67.19 $207,550 279,464
2019-02-08 Darby John Patrick EVP, Gen Counsel & Secretary Other disposed transaction
F
Encompass Health Common Stock 1,305 $65.10 $84,956 21,896
2019-01-16 SHAW L EDWARD JR Dir Equity grant / award
A
Encompass Health Common Stock 60 $66.34 $3,980 88,502
2019-01-15 SHAW L EDWARD JR Dir Equity grant / award
A
Encompass Health Common Stock 269 $0.00 $0 88,442
2019-01-02 Tarr Mark J President & CEO Other disposed transaction
F
Encompass Health Common Stock 9,410 $61.70 $580,597 282,553
2018-10-16 SHAW L EDWARD JR Dir Equity grant / award
A
Encompass Health Common Stock 51 $75.42 $3,846 88,173
2018-10-15 SHAW L EDWARD JR Dir Equity grant / award
A
Encompass Health Common Stock 238 $0.00 $0 88,122
2018-08-14 Price Andrew L Chief Accounting Officer Open-market sell
S
Encompass Health Common Stock 9,457 $80.04 $756,938 65,008
2018-08-03 Levy Cheryl B. Chief Human Resources Officer Open-market sell
S
Encompass Health Common Stock 28,955 $78.00 $2,258,490 39,567
2018-07-17 SHAW L EDWARD JR Dir Equity grant / award
A
Encompass Health Common Stock 52 $68.00 $3,536 87,884
2018-07-16 SHAW L EDWARD JR Dir Equity grant / award
A
Encompass Health Common Stock 237 $0.00 $0 87,832
2018-05-14 Jacobsmeyer Barbara Ann President, Inpatient Hospitals Open-market sell
S
Encompass Health Common Stock 1,798 $62.73 $112,789 32,269
2018-05-09 Levy Cheryl B. Chief Human Resources Officer Open-market sell
S
Encompass Health Common Stock 30,982 $63.00 $1,951,866 68,522
2018-05-04 SHAW L EDWARD JR Dir Equity grant / award
A
Encompass Health Common Stock 2,386 $0.00 $0 87,595
2018-05-02 Jacobsmeyer Barbara Ann President, Inpatient Hospitals Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 3,897 $0.00 $0 7,792
2018-05-02 Jacobsmeyer Barbara Ann President, Inpatient Hospitals Open-market sell
S
Encompass Health Common Stock 3,897 $62.51 $243,601 34,067
2018-05-02 Jacobsmeyer Barbara Ann President, Inpatient Hospitals Exercise / conversion
M
Encompass Health Common Stock 3,897 $42.22 $164,531 37,964
2018-05-01 Tarr Mark J President & CEO Exercise / conversion
M · derivative
Non-qualified Stock Option (Right to Buy) 33,100 $0.00 $0 0
2018-05-01 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 16,575 $61.32 $1,016,379 291,963
2018-05-01 Tarr Mark J President & CEO Open-market sell
S
Encompass Health Common Stock 16,525 $60.60 $1,001,415 308,538
2018-05-01 Tarr Mark J President & CEO Exercise / conversion
M
Encompass Health Common Stock 33,100 $7.85 $259,835 325,063
2018-04-17 CHIDSEY JOHN Dir Equity grant / award
A
Healthsouth Common Stock 626 $57.99 $36,302 105,585
2018-04-16 CHIDSEY JOHN Dir Equity grant / award
A
Healthsouth Common Stock 261 $0.00 $0 104,959
2018-03-01 Tarr Mark J President & CEO Equity grant / award
A · derivative
Non-qualified Stock Option (Right to Buy) 51,547 $0.00 $0 51,547
2018-02-23 Tarr Mark J President & CEO Equity grant / award
A
Healthsouth Common Stock 13,359 $0.00 $0 291,963
2018-02-23 Tarr Mark J President & CEO Equity grant / award
A
Healthsouth Common Stock 26,459 $0.00 $0 278,604
2018-02-20 Tarr Mark J President & CEO Other disposed transaction
F
Healthsouth Common Stock 3,320 $52.10 $172,972 252,145
2018-02-08 Darby John Patrick EVP, Gen Counsel & Secretary Other disposed transaction
F
Healthsouth Common Stock 1,282 $51.47 $65,985 13,205

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
21
Material Event Filings (8-K) — 12 months
12

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.